Meanwhile, treatment with enzalutamide at 50 μM for 72 h led to 140% and 75% cascade activation of caspase-6 in human U87 MG and U87 MG-R glioblastoma cells, respectively (Figure 5D). This evidence concerns the gene CASP6 and glioblastoma.